562 related articles for article (PubMed ID: 8644856)
21. Expression of the complement regulatory protein CD59 on human spermatozoa: characterization and role in gametic interaction.
Fenichel P; Cervoni F; Hofmann P; Deckert M; Emiliozzi C; Hsi BL; Rossi B
Mol Reprod Dev; 1994 Jul; 38(3):338-46. PubMed ID: 7522480
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of the complement regulatory proteins in the human eye.
Bora NS; Gobleman CL; Atkinson JP; Pepose JS; Kaplan HJ
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3579-84. PubMed ID: 7505007
[TBL] [Abstract][Full Text] [Related]
23. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Clayton A; Harris CL; Court J; Mason MD; Morgan BP
Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein upregulates complement-inhibitory factors in endothelial cells.
Li SH; Szmitko PE; Weisel RD; Wang CH; Fedak PW; Li RK; Mickle DA; Verma S
Circulation; 2004 Feb; 109(7):833-6. PubMed ID: 14967730
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins.
Tedesco F; Narchi G; Radillo O; Meri S; Ferrone S; Betterle C
J Immunol; 1993 Aug; 151(3):1562-70. PubMed ID: 7687635
[TBL] [Abstract][Full Text] [Related]
26. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
Ravindranath NM; Nishimoto K; Chu K; Shuler C
Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
[TBL] [Abstract][Full Text] [Related]
27. Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.
Junnikkala S; Jokiranta TS; Friese MA; Jarva H; Zipfel PF; Meri S
J Immunol; 2000 Jun; 164(11):6075-81. PubMed ID: 10820293
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
Seya T; Hara T; Matsumoto M; Akedo H
J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
[TBL] [Abstract][Full Text] [Related]
29. Diminished expression of cell-surface complement regulatory proteins in HIV-infected children and with HIV infection of peripheral blood mononuclear cells in vitro.
Jarvis JN; Taylor H; Long PM; Gutta PV; Pousak T; Fine N
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):249-56. PubMed ID: 7540489
[TBL] [Abstract][Full Text] [Related]
30. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
31. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.
Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I
Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404
[No Abstract] [Full Text] [Related]
32. Immunization against tumor cell surface complement-regulatory proteins.
Durrant LG; Spendlove I
Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
[TBL] [Abstract][Full Text] [Related]
34. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
[No Abstract] [Full Text] [Related]
35. Expression of messenger RNAs for complement inhibitors in human tissues and tumors.
Kumar S; Vinci JM; Pytel BA; Baglioni C
Cancer Res; 1993 Jan; 53(2):348-53. PubMed ID: 7678074
[TBL] [Abstract][Full Text] [Related]
36. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
Capey S; van den Berg CW
Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
[TBL] [Abstract][Full Text] [Related]
37. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
39. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
[TBL] [Abstract][Full Text] [Related]
40. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]